161 – 170 of 309
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2014
-
Mark
Transplantation of mesenchymal stem cells : A future therapy for Parkinson's disease?
(
- Contribution to journal › Scientific review
-
Mark
Mitogen- and stress-activated protein kinase 1 is required for specific signaling responses in dopamine-denervated mouse striatum, but is not necessary for l-DOPA-induced dyskinesia
(
- Contribution to journal › Article
-
Mark
The role of Galectin-3 in α-synuclein-induced microglial activation
(
- Contribution to journal › Scientific review
- 2013
-
Mark
Effect and safety of duodenal levodopa infusion in advanced Parkinson's disease: a retrospective multicenter outcome assessment in patient routine care
(
- Contribution to journal › Article
-
Mark
Cholinergic and dopaminergic aspects of dementia in Parkinson's disease: postmortem neuropathological findings and modeling of cognitive dysfunction in rodents
(
- Thesis › Doctoral thesis (compilation)
-
Mark
Reduced Body Mass Index in Parkinson's Disease: Contribution of Comorbid Depression.
(
- Contribution to journal › Article
-
Mark
Low Dose Bexarotene Treatment Rescues Dopamine Neurons and Restores Behavioral Function in Models of Parkinson's Disease
(
- Contribution to journal › Article
-
Mark
AC-186, a Selective Nonsteroidal Estrogen Receptor beta Agonist, Shows Gender Specific Neuroprotection in a Parkinson's Disease Rat Model
(
- Contribution to journal › Article
-
Mark
Anti-dyskinetic effect of anpirtoline in animal models of L-DOPA-induced dyskinesia
(
- Contribution to journal › Article
-
Mark
Pharmacokinetics of Levodopa, Carbidopa, and 3-O-Methyldopa Following 16-hour Jejunal Infusion of Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson's Disease Patients
(
- Contribution to journal › Article